Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rankning i aktier #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Aktiekurs
$0.05504527
Senast synkroniserad: 2026-08-17
Marknadsvärde
$10.89M
Förändring (1 dag)
15.38%
Förändring (1 år)
-10.64%
Land
CA
Handel Hemostemix Inc. (HEM)

Kategori

Historik för aktiesplit för Hemostemix Inc. (HEM)
Aktien Hemostemix Inc. (symbol: HEM) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 18, 2026.
En HEM-aktie köpt före Aug 18, 2026 motsvarar nu 0 HEM-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR